Flexion Therapeutics Inc Sentiment Increases on Better Stock Potential

FLXN has been the subject of several other reports. The Company's divisions include the Peruvian operations, the Mexican open-pit activities and the Mexican underground mining activities segment identified as the IMMSA unit. Omnicom Group Inc. (NYSE:OMC) has risen 1.15% since September 15, 2016 and is uptrending. The shares were acquired at an average price of $17.02 per share, with a total value of $26,891.60. Novo A S holds 2.53% in Flexion Therapeutics Inc (NASDAQ:FLXN) or 1.40M shares. It has outperformed by 65.32% the S&P500. Riverhead Cap Management Ltd Liability Com reported 128,201 shares.

Investment analysts at RBC Capital now has a $44.0 PT on Flexion Therapeutics (NASDAQ:FLXN). They expect $-0.95 EPS, down 46.15 % or $0.30 from last year's $-0.65 per share. Equities analysts predict that Flexion Therapeutics, Inc. will post ($3.70) EPS for the current fiscal year.

Among 9 analysts covering Flexion Therapeutics (NASDAQ:FLXN), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. FLXN was included in 13 notes of analysts from July 31, 2015. On Friday, July 7 the stock rating was maintained by RBC Capital Markets with "Buy". Needham maintained Flexion Therapeutics Inc (NASDAQ:FLXN) rating on Wednesday, September 9. On Wednesday, November 4 the stock rating was initiated by Cantor Fitzgerald with "Buy". The stock presently has a consensus rating of "Buy" and a consensus price target of $31.50. On Wednesday, June 29 the stock rating was initiated by BMO Capital Markets with "Outperform". RBC Capital Markets maintained it with "Buy" rating and $44.0 target in Monday, September 11 report. The rating was initiated by Lake Street on Thursday, July 21 with "Buy".

Investors sentiment increased to 2.54 in 2016 Q4. Its up 0.55, from 1.19 in 2016Q3. Blackrock Fund Advisors has 0% invested in Flexion Therapeutics Inc (NASDAQ:FLXN) for 1.23M shares. Sold All: 8 Reduced: 16 Increased: 42 New Position: 19.

On Thursday, August 31st, Yamo Deniz purchased 1,375 shares of Flexion Therapeutics stock. Fiduciary Trust Co. purchased a new position in shares of Flexion Therapeutics during the 2nd quarter valued at $101,000. D E Shaw And Company reported 22,100 shares. Gilder Gagnon Howe And Communications Limited Liability Corp invested in 4.38M shares. Sabby Limited Liability Corp holds 10,914 shares. The original version of this article can be viewed at ProShare Advisors LLC increased its stake in shares of Flexion Therapeutics by 5.5% during the 2nd quarter. Alyeska Investment Grp Lp stated it has 0.04% of its portfolio in Flexion Therapeutics Inc (NASDAQ:FLXN). Southport Management L.L.C., a Wyoming-based fund reported 25,000 shares.#img1#.

Flexion Therapeutics, Inc is a United States-based specialty pharmaceutical company. The company has market cap of $753.29 million. The Firm is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. It now has negative earnings. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid.

Since January 1, 0001, it had 3 buys, and 2 insider sales for $360 activity. Another trade for 6,830 shares valued at $129,448 was sold by Bodick Neil. Shares for $86,152 were bought by Clayman Michael D. Another trade for 5,000 shares valued at $85,048 was bought by COLELLA SAMUEL D. $26,888 worth of stock was bought by Stejbach Mark on Friday, June 16. DRISCOLL FREDERICK W sold $69,000 worth of stock. Following the transaction, the insider now directly owns 5,000 shares of the company's stock, valued at $121,000. IFP Advisors Inc now owns 5,080 shares of the specialty pharmaceutical company's stock valued at $103,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Wall Street Associates acquired a new stake in shares of Flexion Therapeutics during the second quarter valued at $1,697,000. The Manufacturers Life Insurance Company now owns 21,802 shares of the specialty pharmaceutical company's stock worth $441,000 after purchasing an additional 811 shares during the last quarter. Southern Copper Corp (SCCO) has risen 28.26% since September 15, 2016 and is uptrending. It has outperformed by 11.56% the S&P500. Cantor Fitzgerald set a $40.00 price objective on Flexion Therapeutics and gave the company a "buy" rating in a research note on Monday, May 22nd. One analyst has rated the stock with a sell rating, seven have issued a buy rating and two have given a strong buy rating to the company. The stock of Southern Copper Corp (NYSE:SCCO) earned "Buy" rating by HSBC on Friday, August 26.

Analysts await Compugen Ltd. (USA) (NASDAQ:CGEN) to report earnings on November, 6. OMC's profit will be $253.79 million for 16.47 P/E if the $1.10 EPS becomes a reality. The specialty pharmaceutical company reported ($0.91) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.80) by ($0.11).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this



18 April 2018
Does Asox9 Have Side Effects?
What Are Asox9's Ingredients? Asox9 was created by Christopher Gordon, a scientist who suffered problems with erection himself. Zinc – Zink is the main compound that can be found in Oysters, which are known to be one of the greatest aphrodisiacs.

11 April 2018
England All-rounder David Willey Replaces Kedar Jadhav
He has two centuries and seven half centuries to his name, which have come while playing in various T20 leagues across the world. With an experience of more than 140 T20 matches, David will prove out to be the Trump Card of Chennai Super Kings this season.

16 September 2017
Market Monitor: SuperTrend Line Below Share Price: Vanguard Ftse Europe Shares Etf
The latest reading places the stock above the Ichimoku cloud which indicates positive momentum and a potential buy signal. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend.

16 September 2017
Altria Group (NYSE:MO) Shares Bought by CIBC World Markets Inc
More interesting news about Altria Group Inc (NYSE:MO) were released by: and their article: "2 Reasons Altria Group Inc". Other institutional investors and hedge funds have also recently made changes to their positions in the company.

16 September 2017
Sabra Healthcare REIT, Inc. - 7 (NASDAQ:SBRAP) Trading Volume Significantly Lower
Investors may be looking to compare the current stock price of Sabra Health Care REIT Inc (SBRA) to some of its moving averages. River Road Asset Management LLC raised its position in shares of Sabra Healthcare REIT by 30.2% during the second quarter.

16 September 2017
Police officers walk over a lady during St. Louis protests
Stockley's lawyer defended his client's statement, chalking it up to typical "human emotion" during a high pressure situation. He and the mayor urged protesters to be peaceful, a sentiment echoed by Smith's fiancée, Christina Wilson.

16 September 2017
Parsec Financial Management Inc. Has $4.45 Million Stake in FedEx Corporation (FDX)
SunTrust maintained The GEO Group Inc (NYSE:GEO) rating on Thursday, September 1. (NASDAQ:IRWD) rating on Friday, February 19. The stock of Vipshop Holdings Ltd - ADR (NYSE:VIPS) earned "Underweight" rating by Morgan Stanley on Thursday, December 17.

16 September 2017
Johnson takes on May with vision for 'glorious' Brexit
Critics warned there is "absolutely no chance" of the £350 million pledge being delivered and said Mr Johnson was untrustworthy. The government itself has made no move to promise such a financial injection for the health service as a result of Brexit.

15 September 2017
ShangriLa is online casino with guarantee of won money pay outs
Shangri La proposes games for any taste A large selection of slot games allows anyone to choose a game for any discerning taste. This is the best place to spend your free time with pleasure, stress relief, relax and forget about the daily problems.

23 June 2017
Marvel Looks To Shake Its Poor Gaming Reputation
The games are well designed with attractive graphics and extensive content, but neither is viewed as a flawless experience. These games tend to be actually well done for what they are, and in a way they’ve been the pride of Marvel gaming.